UPC Stock Analysis: Buy, Sell, or Hold?
UPC - Universe Pharmaceuticals Inc. Ordinary Shares
$2.56
-0.20 (-7.25%)
▼
5d:
-3.4%
30d:
-24.26%
90d:
-4.48%
BUY
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: Apr 22, 2026
0d
Get Alerted When UPC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: UPC shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: UPC shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: UPC is currently trading at $2.56, which is considered oversold relative to its 30-day fair value range of $2.80 to $3.30.
Technical Outlook: Technically, UPC is in a downtrend. The price is currently testing key support at $2.56. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, UPC is in a downtrend. The price is currently testing key support at $2.56. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.80 -
$3.30
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.2%)
Trading Range Analysis
30-Day Trading Range
$2.80 -
$3.30
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.56
Resistance Level
$3.45
Current Trend
Downtrend
Technical data as of
May 18, 2026
Fundamental Context
Revenue Growth (YoY)
-14.1%
Earnings Growth (YoY)
-82.0%
Profit Margin
-20.6%
Share & Embed Analysis
Last updated: May 18, 2026 1:19 PM ET
Data refreshes hourly during market hours. Next update: 2:19 PM
Data refreshes hourly during market hours. Next update: 2:19 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is UPC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$191 | 63 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$131 | 57 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$104 | 59 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 65 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 58 HOLD |
